Corporate venture funds fill drop off in biotech investment

11/15/2011 | Bloomberg Businessweek

Corporate venture funds are increasingly filling biotech firms' funding needs, according to analysts. Corporate venture funds were tied to 25% of early-stage U.S. biotech financing deals during the first half of 2011, compared with 15% in all of 2010, according to PricewaterhouseCoopers and the National Venture Capital Association. Amgen Ventures said it has funded 26 companies since it started in 2004.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA